ANAVEX LIFE SCIENCES CORP (AVXL) — insider trading
Health Care · NASDAQ
ANAVEX LIFE SCIENCES CORP (AVXL) has 14 reported SEC Form 4 insider transactions in our data (latest 2026-01-06).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-06 | Boenisch Sandra | Officer (PFO & Treasurer) | Grant / award / vesting (derivative) | 12,500 | $0.00 | $0 | Form 4 |
| 2026-01-06 | MISSLING CHRISTOPHER U | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 125,000 | $0.00 | $0 | Form 4 |
| 2025-10-02 | MISSLING CHRISTOPHER U | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 125,000 | $0.00 | $0 | Form 4 |
| 2025-10-02 | Boenisch Sandra | Officer (PFO & Treasurer) | Grant / award / vesting (derivative) | 12,500 | $0.00 | $0 | Form 4 |
| 2025-09-11 | MISSLING CHRISTOPHER U | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 187,500 | $0.00 | $0 | Form 4 |
| 2025-09-11 | MISSLING CHRISTOPHER U | Director, Officer (President and CEO) | Shares withheld for taxes / exercise cost | 145,048 | $9.58 | $1.39M | Form 4 |
| 2025-09-11 | MISSLING CHRISTOPHER U | Director, Officer (President and CEO) | Option exercise / conversion | 187,500 | $5.04 | $945.0K | Form 4 |
| 2025-08-20 | MISSLING CHRISTOPHER U | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 125,000 | $0.00 | $0 | Form 4 |
| 2025-08-20 | Boenisch Sandra | Officer (PFO & Treasurer) | Grant / award / vesting (derivative) | 12,500 | $0.00 | $0 | Form 4 |
| 2025-06-05 | Thomas Steffen | Director | Option exercise / conversion (derivative) | 50,000 | $0.00 | $0 | Form 4 |
| 2025-06-05 | Thomas Steffen | Director | Shares withheld for taxes / exercise cost | 11,349 | $7.75 | $88.0K | Form 4 |
| 2025-06-05 | Thomas Steffen | Director | Option exercise / conversion | 50,000 | $1.76 | $88.0K | Form 4 |
| 2025-04-28 | MISSLING CHRISTOPHER U | Director, Officer (President and CEO) | Grant / award / vesting (derivative) | 125,000 | $0.00 | $0 | Form 4 |
| 2025-04-28 | Boenisch Sandra | Officer (PFO & Treasurer) | Grant / award / vesting (derivative) | 12,500 | $0.00 | $0 | Form 4 |
Ask the chat about AVXL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ANAVEX LIFE SCIENCES CORP (AVXL).
Last updated 2026-01-06 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.